Guggenheim on Abivax (ABVX): 'We expect ABVX to get a late-breaker and/or a plenary session at the UEGW'
Tweet Send to a Friend
Guggenheim analyst Yatin Suneja reiterated a Buy rating and $101.00 price target on Abivax (NASDAQ: ABVX).The analyst comments "Today, UEGW ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
